Fractyl Logo Patients

After a decade in the type 2 diabetes game, Fractyl Laboratories recharges with a fresh $100M and a new name

Endpoints News

Read more 

You are now leaving the website

You are leaving Fractyl’s main website to go to Fractyl’s U.K. site.

By selecting Continue you will be directed to Fractyl’s U.K. site. If you would like to remain on Fractyl’s main site, select the Cancel button.